Search Results

You are looking at 1 - 3 of 3 items for

  • Author: R Arnold x
  • Refine by access: All content x
Clear All Modify Search
G. Richter
Search for other papers by G. Richter in
Google Scholar
PubMed
Close
,
R. Göke
Search for other papers by R. Göke in
Google Scholar
PubMed
Close
,
B. Göke
Search for other papers by B. Göke in
Google Scholar
PubMed
Close
, and
R. Arnold
Search for other papers by R. Arnold in
Google Scholar
PubMed
Close

ABSTRACT

The effect of dexamethasone on binding of glucagonlike peptide-1(7–36)amide (GLP-1(7–36)amide) to rat insulinoma-derived cells (RINm5F) was investigated. Preincubation of RINm5F cells with dexamethasone (100 nmol/l) for 24 h resulted in a decrease of GLP1(7-36)amide binding to 55·0±8·16% (mean ± s.e.m.), incubation for 48 h to 39·1±1·76%, and for 72 h to 15·5±4·35% of maximal binding. The GLP-1(7–36)amide-induced stimulation of cyclic AMP (cAMP) production was significantly decreased to 61·03±7·4% of maximum production in cells pretreated with dexamethasone (100 nmol/l) for 48 h. The decreased binding was due to a reduction of the receptor number while the receptor affinity remained unchanged. These inhibitory effects on binding and cAMP formation induced by dexamethasone were completely abolished when the antiglucocorticoid RU 38486 (100 nmol/l) was added during preincubation with dexamethasone. RU 38486 alone had no effects. Our data suggest that the biological action of GLP-1(7–36) amide at the B-cell may be modified by glucocorticoids.

Journal of Endocrinology (1990) 126, 445–450

Restricted access
D.E. Arnold-Reed
Search for other papers by D.E. Arnold-Reed in
Google Scholar
PubMed
Close
and
R.J. Balment
Search for other papers by R.J. Balment in
Google Scholar
PubMed
Close

ABSTRACT

Atrial natriuretic factor (ANF) has been shown to increase circulating cortisol levels in cannulated, free-swimming seawater (SW)-adapted flounders. Increases were apparent within 30 min of i.v. injection of human ANF hANF; 10μg/kg bw) and the increase in plasma cortisol was maintained throughout the 5h experimental period. No such increase was observed in vehicle-injected controls. This apparent steroidogenic effect of ANF was supported by an ANF-induced increase in in-vitro secretion of cortisol by interrenal tissue from SW-adapted trout. By contrast hANF had no significant effect on tissue derived from freshwater adapted trout. An ANF-induced increase in plasma cortisol by a direct effect on interrenal steroidogenesis in SW teleosts would be an appropriate response for survival in hypertonic media.

Restricted access
J Schirra
Search for other papers by J Schirra in
Google Scholar
PubMed
Close
,
P Leicht
Search for other papers by P Leicht in
Google Scholar
PubMed
Close
,
P Hildebrand
Search for other papers by P Hildebrand in
Google Scholar
PubMed
Close
,
C Beglinger
Search for other papers by C Beglinger in
Google Scholar
PubMed
Close
,
R Arnold
Search for other papers by R Arnold in
Google Scholar
PubMed
Close
,
B Goke
Search for other papers by B Goke in
Google Scholar
PubMed
Close
, and
M Katschinski
Search for other papers by M Katschinski in
Google Scholar
PubMed
Close

Twelve patients with non-insulin dependent diabetes mellitus (NIDDM) under secondary failure to sulfonylureas were studied to evaluate the effects of subcutaneous glucagon-like peptide-1(7-36)amide (GLP-1) on (a) the gastric emptying pattern of a solid meal (250 kcal) and (b) the glycemic and endocrine responses to this solid meal and an oral glucose tolerance test (OGTT, 300 kcal). 0.5 nmol/kg of GLP-1 or placebo were subcutaneously injected 20 min after meal ingestion. GLP-1 modified the pattern of gastric emptying by prolonging the time to reach maximal emptying velocity (lag period) which was followed by an acceleration in the post-lag period. The maximal emptying velocity and the emptying half-time remained unaltered. With both meals, GLP-1 diminished the postprandial glucose peak, and reduced the glycemic response during the first two postprandial hours by 54.5% (solid meal) and 32.7% (OGTT) (P < 0.05). GLP-1 markedly stimulated insulin secretion with an effect lasting for 105 min (solid meal) or 150 min (OGTT). The postprandial increase of plasma glucagon was abolished by GLP-1. GLP-1 diminished the postprandial release of pancreatic polypeptide. The initial and transient delay of gastric emptying, the enhancement of postprandial insulin release, and the inhibition of postprandial glucagon release were independent determinants (P < 0.002) of the postprandial glucose response after subcutaneous GLP-1. An inhibition of efferent vagal activity may contribute to the inhibitory effect of GLP-1 on gastric emptying.

Free access